Mutant calreticulin-driven myeloproliferative neoplasms favour the emergence of TIGIT-positive NK cells
Leukemia - Mutant calreticulin-driven myeloproliferative neoplasms favour the emergence of TIGIT-positive NK cells
Leukemia - Mutant calreticulin-driven myeloproliferative neoplasms favour the emergence of TIGIT-positive NK cells